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Lyme disease is a long-term infection whose most severe pathology is characterized
by inflammatory arthritis of the lower bearing joints, carditis, and neuropathy. The
inflammatory cascades are initiated through the early recognition of invading Borrelia
burgdorferi spirochetes by cells of the innate immune response, such as neutrophils and
macrophage. B. burgdorferi does not have an intracellular niche and thus much research
has focused on immune pathways activated by pathogen recognition molecules at the
cell surface, such as the Toll-like receptors (TLRs). However, in recent years, studies have
shown that internalization of the bacterium by host cells is an important component of
the defense machinery in response to B. burgdorferi. Upon internalization, B. burgdorferi
is trafficked through an endo/lysosomal pathway resulting in the activation of a number of
intracellular pathogen recognition receptors including TLRs and Nod-like receptors (NLRs).
Here we will review the innate immune molecules that participate in both cell surface and
intracellular immune activation by B. burgdorferi.
Keywords: Borrelia burgdorferi , Lyme disease, Toll-like receptor signaling, Nod-like receptor signaling,
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INTRODUCTION
Lyme disease is caused by the spirochete Borrelia burgdorferi
transmitted through a tick bite. The disease manifests as early
localized skin inflammation (erythema migrans) occurring at the
site of the tick bite. Late stage disease is characterized by inflam-
mation of the heart, the joints, the nervous system or the skin.
The incidence of human infections has risen steadily over the last
15 years and Lyme disease is the most common tick-borne dis-
ease in the United States and Europe. More than 30,000 cases are
reported annually in the US and the number of cases is estimated
around 85,000 yearly in Europe (Lindgren et al., 2006; Centers for
Disease Control and Prevention, 2013).
Innate immune responses are the first responders to infec-
tion and the catalyst of inflammation causing much of Lyme
disease pathology. Recently, studies have shown that phagocy-
tosis plays a role in initiating inflammatory responses (Moore
et al., 2007; Shin et al., 2008; Salazar et al., 2009). Because of
the requirement for pathogen internalization, much interest has
been generated in studying intracellular signaling pathways. As a
result, in addition to pathogen recognition by Toll-like receptors
(TLRs), intracellular receptors such as the NOD-like receptors
(NLRs) have been shown to participate in B. burgdorferi signal-
ing. These families of receptors do not act in isolation and there
is considerable cross talk among the innate immune signaling
pathways activated (Takeuchi and Akira, 2010). TLR2 has been
shown to initiate a significant portion of the inflammatory output
in response to B. burgdorferi. The TLR2 ligands are Borrelia cell
surface lipoproteins, the best-characterized being Outer Surface
Protein A (OspA) (Hirschfeld et al., 1999; Lien, 1999; Takeuchi
and Akira, 2010).
Cellular compartmentalization is increasingly recognized as
having a significant role in the regulation of innate immune sig-
naling. Although this concept has been broadly understood as
distinguishing between cell surface receptors, such as TLRs 2, 4,
and 5 and intracellular sensors, such as TLRs 3, 7, and 9, as well as
NLRs, it has recently become apparent that intracellular traffick-
ing to different sub-cellular compartments and organelles, such
as mitochondria and peroxisomes, plays a more intricate role in
innate immune regulation than previously thought (Eisenbarth
and Flavell, 2009; Blasius and Beutler, 2010; Dixit et al., 2010;
Kagan, 2012). Here we will review various intracellular innate
immune pathways activated by B. burgdorferi and how they may
collectively contribute to inflammatory signaling.
TOLL-LIKE RECEPTORS
CELL SURFACE SIGNALING
Recognition of B. burgdorferi at the cell surface
Due to the importance of bacterial phagocytosis into host cells,
significant research in recent years has been devoted to under-
stand the involvement of cell surface molecules in the inter-
nalization of B. burgdorferi. Spirochete internalization involves
attachment or tethering of the bacteria to the host cell followed
by engulfment into the host cell. These two processes, although
linked, often involve different sets of cells surface molecules.
B. burgdorferi contains a number of molecules known to function
as adhesins and participate in the attachment of the bacterium
to the host cell. One group of receptors shown to participate in
tethering of B. burgdorferi to the cell surface is the integrin family,
specifically integrins αvβ3, α5β1,and αMβ2(CD18/CD11b, Mac-1,
CR3) (Cinco et al., 1997; Coburn et al., 1998). Integrin αvβ3has
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been shown to bind to the p66 protein of B. burgdorferi, but has
not been shown to play a direct role in the initiation of immune
responses (Coburn et al., 1998; Coburn and Cugini, 2003). It
does, however, participate in adherence and potentially internal-
ization of the bacterium into the host cell. Interestingly, integrin
αvβ3 has been suggested to tether TLR2 ligands to the host cell
via interaction with the serum protein vitronectin (Gerold et al.,
2008). This has not been explored in the context of B. burgdor-
feri adhesion. Integrin αMβ2 has been shown to participate in the
attachment of B. burgdorferi to the cell surface (Cinco et al., 1997)
and together with the TLR2 associated GPI anchored receptor,
CD14, αMβ2 mediates the internalization of the bacterium into
the host cell (Hawley et al., 2012).
Signal transduction from the cell surface
Signaling from the plasma membrane is a necessary compo-
nent of the B. burgdorferi response, the mechanisms of which
remain to be completely described. Understanding how cell sur-
face accessory molecules contribute to the recognition of the
ligand by the TLR is an active area of research. In the model of
TLR4 signaling, integrin αMβ2 participates in the recruitment of
the Toll-interleukin 1 receptor (TIR) domain-containing adapter
protein (TIRAP) to Phosphatidylinositol 4,5-bisphosphate (PIP2)
rich membranes, where TIRAP interacts with PIP2 and initiates
cells surface signaling by recruiting the MyD88 signaling adaptor
(Kagan and Medzhitov, 2006). TLR2 is the only other TLR that
has been shown to utilize TIRAP for signaling and thus is likely
that interaction with PIP2 is also important for TLR2 signaling
(Yamamoto et al., 2002). However, there is significant interest in
uncovering the signaling mechanism behind the ability of αMβ2
to traffic ligands and the TLR receptor to PIP2 rich locations and
recruit signaling molecules.
B. burgdorferi does not contain lipopolysaccharide (LPS) and
does not activate TLR4 (Takayama et al., 1987; Berende et al.,
2010). However, it contains other ligands that activate different
TLRs. Specifically, B. burgdorferi activates TLR2/1 heterodimers
through recognition of the triacylated lipid moiety on its cell sur-
face localized lipopeptides (Hirschfeld et al., 1999; Alexopoulou
et al., 2002). B. burgdorferi has been shown to activate TLR5,
potentially through the spirochetal flagellin (Shin et al., 2008).
Recruitment of MyD88 to the plasma membrane by TIRAP for
TLR2 signaling or directly to TLR5 results in a signaling cascade
which proceeds through the recruitment of the IRAK kinases,
the E3 ubiquitin ligase, TRAF6, and TAK1 leading to the acti-
vation of MAP kinases and of NF-kB through the IKK complex
(Takeda and Akira, 2004). This signaling pathway leads to the
activation of pro-inflammatory cytokines such as IL-6, IL-12,
TNF-α, and pro-IL1β. Type I IFNs have not been shown to
be activated from this signaling cascade initiated at the plasma
membrane.
INTRACELLULAR SIGNALING
Internalization of B. burgdorferi into host cells
Although there are a number of cell surface molecules that medi-
ate phagocytosis of B. burgdorferi, the signaling events during
the process of internalization are under investigation. Early stud-
ies into the mechanisms behind B. burgdorferi internalization
indicate that it occurs through coiling, rather than conventional,
phagocytosis, in which the bacteria attach to the host cell surface
and are rolled into a single fold of the plasma membrane (Rittig
et al., 1992). In studies with primary human macrophages it was
shown that interaction with the bacteria leads to the formation
of f-actin rich structures. The actin polymerization is medi-
ated by the Wiskott-Aldrich syndrome family protein (WASP)
and Arp2/3 complex, particularly during integrin αMβ2and Fcγ
receptor mediated phagocytosis (Linder et al., 2001; Shin et al.,
2009). The regulatory pathways influencing actin polymeriza-
tion and internalization of B. burgdorferi are mediated by the
small GTPases Cdc42 and Rac1 (Linder et al., 2001). In addi-
tion, PI3K signaling was shown to be required for phagocytosis
of B. burgdorferi by murine macrophages (Shin et al., 2009).
Although some cell surface molecules may serve as tethers,
othermolecules seem to have amore direct role in internalization.
As described, CD14 is a molecule that mediates endocytosis of
B. burgdorferi (Hawley et al., 2012). However, this is in itself a con-
fusing finding in that CD14 is not known to have any cytoplasmic
signaling domains that could initiate a signaling cascade leading
to phagocytosis. CD14 has been shown to bind integrin αMβ2
and localize it to lipid rafts and it is possible that it then interacts
with other molecules that can mediate endocytosis (Hawley et al.,
2013). The primary role of this integrin seems to be in the attach-
ment of the B. burgdorferi, rather than its internalization, and the
signaling pathways activated by the integrin to mediate phago-
cytosis have not been described in the context of B. burgdorferi.
Interestingly, integrin α3β1 has been shown tomediate B. burgdor-
feri and TLR2/1 ligand signaling (Marre et al., 2010). However,
unlike αMβ2, α3β1 was not shown to mediate the attachment
of B. burgdorferi or other TLR2 ligands to the cell surface but
rather to participate in internalization (Behera et al., 2006; Marre
et al., 2010). Overall, the β1integrin is required for internaliza-
tion of B. burgdorferi into murine fibroblasts and to utilize the Src
kinase signaling pathway for internalization (Wu et al., 2011). It
is unclear if α3β1directly activates the Src signaling cascade, nor
if CD14 and integrin α3β1 cooperate to mediate phagocytosis of
B. burgdorferi.
The complexity of molecule involvement in the phagocytic
process is increased by the added role of scavenger recep-
tors, which have also been shown to participate in TLR2 and
B. burgdorferi signaling. CD36, a type B scavenger receptor, has
been shown to be important for the internalization of TLR2 lig-
ands and numerous studies have been devoted to understanding
the mechanisms behind CD36 cooperation with TLR2. However,
its role in B. burgdorferi internalization has not been explored
(Shamsul et al., 2010). The scavenger receptor Macrophage
Receptor with Collagenous Structure (MARCO), which plays a
role in the internalization of a variety of microbial ligands, does
mediate B. burgdorferi phagocytosis. In our studies we showed
that MARCO was significantly up-regulated upon B. burgdorferi
stimulation. The up-regulation of MARCO was dependent on
MyD88 and MARCO deficient macrophage showed a decrease
in the phagocytosis of B. burgdorferi (Petnicki-Ocwieja et al.,
2013). These findings offered one possible explanation for the
partial phagocytic defect previously observed in MyD88 deficient
macrophage (Shin et al., 2008; Petnicki-Ocwieja et al., 2013). It is
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yet unclear if MARCO participates in B. burgdorferi attachment
to the cell surface. Significant work still needs to be done to
determine how these cell surface accessory molecules: integrins,
scavenger receptors and the GPI anchored receptor, CD14, coop-
erate to mediate signaling and internalization of B. burgdorferi
into the host cell.
Signal transduction from the endosomal compartment
TLR signaling can be initiated from both the plasma membrane
and intracellular compartments. TLR5 has not been shown to
signal from intracellular compartments and thus will not be dis-
cussed further in this context. Interestingly, we and others have
recently shown that in addition to being localized at the plasma
membrane, TLR2 mediates signaling from endosomal vesicles in
response to B. burgdorferi and TLR2 synthetic ligands. Inhibition
of endosomal acidification upon B. burgdorferi stimulation results
in a decrease in type I IFN and pro-inflammatory cytokine
activation, such as IL-6 (Marre et al., 2010; Cervantes et al.,
2011). TLR2 cooperates with other endosomal TLRs to generate a
B. burgdorferi specific inflammatory response. B. burgdorferi acti-
vates TLR7/8 and TLR9, which are endosomally localized TLR
receptors (Shin et al., 2008; Petzke et al., 2009; Cervantes et al.,
2011, 2013). Adaptor molecules, such as MyD88, are recruited
to the endosomal compartment to transduce signals for the acti-
vation of inflammatory cytokines and type I IFN from these
endosomal TLRs (for a detailed review on TLR 7/8 and 9 in
B. burgdorferi signaling, please see Cervantes, Hawley and Salazar
in this issue).
The localization of TLR2 at two different cellular locations
requires that signaling molecules are able to distinguish the cel-
lular localization of TLRs and assemble cell location specific
signaling complexes. The only other TLR that has been shown to
signal from two different cellular locations is TLR4. In the model
of TLR4 signaling, signaling pathways from the cell surface vs.
the endosome are clearly distinguished. TLR4 mediates signaling
from the plasma membrane via TIRAP/MyD88 for MAP kinase
and NF-kB activation resulting in pro-inflammatory cytokine
activation. From the endosome TLR4 utilizes an entirely different
set of adaptors, TRAM and TRIF, which are the signaling plat-
form used to signal for type I IFNs, although TRAM/TRIF also
mediate a delayed wave of NF-kB and pro-inflammatory cytokine
activation (Kawai and Akira, 2011).
Investigating the TLR2 signaling complex at the plasma mem-
brane in comparison to the endosome, we found that TLR2 was
also able to utilize the adaptor TRIF. TRIF deficient macrophage
showed a reduction in type I IFN activation and secretion of IL-6
(Petnicki-Ocwieja et al., 2013). This was an unexpected result as
TRIF was previously thought not to participate in TLR2 signaling.
Interestingly, as opposed to the clear separation of signaling path-
ways in the TLR4 model, TLR2/TRIF signaling was dependent
on MyD88, suggesting that the MyD88 and TRIF signaling path-
ways were interconnected. In addition to participating in TLR7/8
and 9 signaling, MyD88 may also participate in TLR2 signal-
ing at the endosome. In vivo, TRIF deficient mice did not show
any deficiencies in the ability to control bacterial loads in the
joints of B. burgdorferi infected mice in comparison to wild type
mice (Petnicki-Ocwieja et al., 2013). However, TRIF deficient
mice did have increased levels of inflammatory cytokines in the
joints, suggesting that TRIF has an important role in controlling
immune responses leading to inflammation but not responses
leading to control of pathogen burden. This might in part be due
to the fact that, unlike MyD88 deficient cells, TRIF deficient cells
do not have any observable phagocytic defects.
Intracellular activation of immune pathways has been exten-
sively studied in the case of viral infections. The intracellular
activation of type I interferons (IFNs) was for a long time consid-
ered to be strictly a viral response. Recently, type I IFN activation
has been shown to play an important role in a large number
of bacterial infections (Katze et al., 2002; Perry et al., 2005). In
B. burgdorferi infection, the type I IFN response has also been
shown to be important for the development of murine Lyme
arthritis (Miller et al., 2008; Petzke et al., 2009; Salazar et al., 2009;
Cervantes et al., 2011). Type I IFN activation initiated by TLRs is
mediated by interferon regulatory factors (IRFs). In studies with
TLR2 signaling, IRF1, and IRF7, both of which have been shown
to bind MyD88, participate in TLR2 signaling (Dietrich et al.,
2010). Downstream of the adaptor TRIF, TRAF3 is responsible
for localizing an IRF3 signaling complex to the endosome lead-
ing to type I IFN activation. B. burgdorferi stimulation has also
been shown to proceed through IRF7 via TLR2 and TLR7 and 9
(Petzke et al., 2009; Petnicki-Ocwieja et al., 2013). Interestingly,
studies have also shown that IRF3 is required for the type I IFN
response to B. burgdorferi (Miller et al., 2010).
NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN
RECEPTORS (NOD-LIKE RECEPTORS)
TLRs sense the extracellular and the endosomal compart-
ments whereas RIG-like receptors (RLRs) and Nod-like receptors
(NLRs) are intracellular sensors. In addition to TLRs, NLRs
also participate in B. burgdorferi mediated intracellular signal-
ing. From the receptors in the NLR family, Nod1, and 2 and the
inflammasome complex are the best studied.
NOD1 AND NOD2
Nod1 and Nod2 multi-domain proteins in the NLR family and
are involved in the recognition of intracellular pathogens. NLRs
contain an N-terminal effector domain which is thought to
participate in protein-protein interactions with downstream sig-
naling molecules, a central nucleotide-binding oligomerization
domain (NBD or NACHT), and a C-terminal leucine-rich repeat
domain for ligand recognition (LRR). Members of the NLR fam-
ily can be sub-divided based on their N-terminal domain, which
can be a Caspase Recruitment Domain (CARD), a pyrin domain
(PYR), or a baculovirus IAP repeat domain (BIR) (Kanneganti
et al., 2007) (Wilmanski et al., 2007). Many NLRs are complexed
into the inflammasome, a signaling platform which activates
caspase-1. Others, such as Nod1 and Nod2 are not considered
to be inflammasome components and instead recruit the RIP2
kinase (or RICK) through a CARD-CARD interaction leading
to the expression of pro-inflammatory cytokines (Moreira and
Zamboni, 2012). Nod1 and Nod2 cytoplasmic receptors sense
intracellular bacteria through muropeptides derived from bac-
terial peptidoglycans although some data suggest they are also
able to sense viruses and protozoan parasites (Strober et al.,
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2005). In vitro stimulation of Nod2 deficient macrophage with
B. burgdorferi results in a decrease in pro-inflammatory and type
I IFN induction, suggesting Nod2 plays a role in the activation
of inflammatory signals (Sterka and Marriott, 2006; Chauhan
et al., 2009; Oosting et al., 2010a; Petnicki-Ocwieja et al., 2011).
Nod1 does not seem to play a significant role in B. burgdorferi
signaling.
In contrast to the pro-inflammatory effect of Nod2 in vitro, the
opposite pattern is observed in vivo. Nod2 deficiency results in
increased inflammation in the heart and joints after B. burgdor-
feri infection in vivo. This in vivo finding suggests that Nod2 is
also involved in the suppression of the inflammatory signal dur-
ing B. burgdorferi infection (Petnicki-Ocwieja et al., 2011). Nod2
has been extensively studied in other in vivo inflammationmodels
and in some systems, Nod2 deficiency results in increased rather
than decreased pathology, as we have observed for B. burgdorferi.
Such cases include chronic M. tuberculosis infection (Gandotra
et al., 2007) and the Inflammatory Bowel Disorder–Crohn’s dis-
ease, to which Nod2 mutations have been genetically linked
(Hugot et al., 2001; Netea et al., 2004). A possible explanation
for our in vivo observations may lie in the long-term nature of
the infection. Prolonged stimulation of Nod2, similar to endo-
toxin/LPS mediated tolerance, results in the downregulation of
pro-inflammatory cytokines in the intestinal environment, thus
maintaining homeostasis (Hedl et al., 2007). In the context of
B. burgdorferi infection, we hypothesized that Nod2 might play
a role in controlling over exuberant inflammation in vivo, pos-
sibly via a mechanism of tolerance through stimulation of Nod2
or other PRRs (Petnicki-Ocwieja et al., 2013). Thus, Nod2 may
have roles in both resistance to microorganisms and also in tol-
erance to microbial stimulation. The signals, which lead Nod2
to switch from its inflammatory role to its tolerance function,
remain unknown.
INFLAMMASOME
Inflammasomes, described in 2002 (Martinon et al., 2002), are
multi-protein complexes that recognize diverse stimuli such as
pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs). These complexes are
formed in response to inflammation and control the production
of pro-inflammatory cytokines especially interleukin-1β (IL1β)
and interleukin-18 (IL18). Their formation is initiated in the
cell cytosol and comprises a NLR receptor, an adaptor pro-
tein ASC (Apoptosis-associated Speck-like protein containing
a C-terminal CARD) and the cysteine protease caspase-1. The
recruitment of caspase-1 to the inflammasome leads to its pro-
teolytic activation. The activated caspase cleaves pro-IL1β and
pro-IL18 into their active secreted form (Couillin et al., 2011;
Strowig et al., 2012). Caspase-1 is also known to be involved
in the activation of the NF-kB pathway resulting in expression
of other pro-inflammatory cytokines and in cell death. Among
the inflammasomes, the NLRP3 complex is the best character-
ized and has been looked at in the context of B. burgdorferi,
although no significant inflammatory phenotype in vivo was
observed (Eisenbarth and Flavell, 2009; Oosting et al., 2012).
NLRP3 has been shown to recognize a large number of micro-
bial and non-microbial stimuli (MDP, nucleic acids, toxins, silica,
urate crystals etc.) but other proteins of the NLR family that rec-
ognize flagellin (NLRC4/IPAF) might also play a role (Franchi
et al., 2010).
Clinical manifestations of Lyme disease can involve inflamma-
tion of the skin, joints and heart (Steere, 2001). Cytokine levels
measured in erythema migrans lesions from Lyme patients have
revealed the presence of IFNγ but also IL1β and IL6 (Müllegger
et al., 2000). In addition, IL1β and IL18 levels are elevated in
serum of patients presenting Lyme arthritis (Pietruczuk et al.,
2006). In vitro it has been shown that IL1β is secreted by human
PBMC after phagocytosis of live B. burgdorferi (Cruz et al., 2008).
Despite the presence of cytokines that are the result of inflam-
masome activation, the role of the inflammasome in the host
immune response to B. burgdorferi is not clear.
Mice deficient in caspase-1 and ASC, had no effect on host
defense against B. burgdorferi in vivo (Liu et al., 2009). However,
Oosting et al. demonstrated that B. burgdorferi activates the
inflammasome and the production of IL-17 through a caspase-
1-dependent mechanism in an in vivo model of Lyme arthritis
(Oosting et al., 2010b). Both studies were done in knockout mice
that were later described as double knockout for caspase-1 and
caspase-11, suggesting that some of the phenotypes observed may
be attributed to the deficiency in caspase-11 (Kayagaki et al.,
2012). Recently a paper using mice lacking only caspase-1 showed
that acute Lyme arthritis seems to be dependent on the adaptor
ASC and caspase-1 (Oosting et al., 2012). These different results
regarding the role of caspase-1 and ASC may be due to the fact
that the infection models used in the studies differed in the route
of inoculation and the time points examined. As a result, the role
of the inflammasome in B. burgdorferi infection remains unclear.
One hypothesis that may resolve some of the discrepancies is that
the inflammasome may have a different role during acute and
chronic phases of infection.
OTHER INTRACELLULAR PATHWAYS
While studies have found that the activation of type I IFNs is
driven by endosomal TLRs and Nod2, other studies have found
that type I IFN signaling is TLR and Nod2 independent (Miller
et al., 2008). Although differences in the types of knockout cells
or activation state of themacrophage are possible explanations for
such discrepancies, it is likely that at least part of the type I IFN
response generated occurs via other intracellular sensors. A recent
study suggests that TLR independent type I IFN signals may be
responsible for naïve B cell accumulation in Lyme disease (Hastey
et al., 2014). The involvement of members of the RLR family, such
as the dsRNA receptors RIG-1 or MDA5, or the DNA-sensing
AIM2 inflammasome complex, remains to be explored in the con-
text of B. burgdorferi infection. Alternatively, it is possible none of
the above mentioned sensors may be responsible for a type I IFN
response. Miller et al. showed in their studies that supernatants
from log phase cultures of B. burgdorferi were still able to induce
IFN gene-related transcripts even when the supernatants were fil-
tered and treated with DNase and RNase, excluding recognition
by RLRs or AIM2 (Miller et al., 2010). Thus, it is possible that
there is a soluble and possibly secreted B. burgdorferi non-nucleic
acid ligand that activates type I IFNs via IRF3. In this case, both
the sensor and the ligand remain to be identified.
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FIGURE 1 | Extracellular and intracellular signaling pathways mediated
by B. burgdorferi. Overview of the pathogen recognition receptors
(PRRs) involved in the recognition and signaling in response to
B. burgdorferi. Cell surface signaling is primarily mediated by TLR2/1
leading to pro-inflammatory cytokine production. Integrins and CD14 are
known to recognize and internalize the spirochete but their role in
intracellular signaling is not fully understood. Intracellular receptors located
at the endosome, in particular TLR2/1, TLR7/8, and TLR9, are activated by
different B. burgdorferi ligands and recruit adaptors such as MyD88 and/or
TRIF to transduce signals for the activation of inflammatory cytokines and
type I IFNs. The Nod2 receptor also plays a role in recognition of
B. burgdorferi and in the induction of inflammatory responses, but it
might have a dual regulatory role depending on the stage of infection.
The inflammasome is likely to be involved, however, in vivo, it is unclear
whether the inflammasome is required for the development of host
responses to the pathogen.
CONCLUSIONS
The innate immune system rapidly responds to the presence of
pathogens. Although there are a number of receptors localized at
the cell surface that detect invasive pathogens before they enter
the cells, there is also an entire network of “second-wave” intra-
cellular receptors that alert the host to a microbial presence.
Thus, immune responses to microbial invasion are comprised of
a signaling network involving multiple receptors (Figure 1).
The contribution of a number of these intracellular recep-
tors to pathogen infection may not be in the aspect of bac-
terial clearance but rather in exacerbating the inflammatory
response. We have seen evidence of this in mice deficient in
Nod2 and TRIF, which do not affect pathogen burden but do
affect severity of inflammation (Petnicki-Ocwieja et al., 2011,
2013). Treatment of Lyme arthritis requires the use of antimi-
crobials to clear the pathogen (Wormser et al., 2006). However,
due to the fact that much of the pathology is a result of
excessive inflammation, there could be a clinical application
for immunomodulatory drugs. Thus, understanding intracellular
signaling pathways engaged by B. burgdorferi could lead to
the development of anti-inflammatory treatments that, when
necessary, could be used in combination therapy for Lyme
arthritis.
One receptor we have focused on is TLR2, which has been
shown to be responsible for a significant portion of B. burgdor-
feri initiated pro-inflammatory signaling. However, studies have
shown that other TLRs, such as TLR7/8 and TLR9 also signal for
the activation of inflammatory responses, including type I IFNs
(Petzke et al., 2009; Salazar et al., 2009; Cervantes et al., 2011,
2013). Futhermore, TLR2 and TLR8 were shown to cooperate in
response to B. burgdorferi (Cervantes et al., 2011). In addition,
Nod2 has also been shown to play a role in mediating some of the
B. burgdorferi inflammatory response. Thus, the B. burgdorferi-
induced inflammatory signature is a result of contribution of
multiple receptors.
It is unclear how the cell directs this signaling network. In
recent years it has been shown that localization to different cel-
lular compartments plays a significant role in coordinating the
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activation of innate immune pathways. The broad classification of
cell surface being distinct from intracellular receptors is no longer
sufficient when describing the complexity of signaling pathways.
Although “intracellular” is used to broadly imply endosomal
localization it is now known that immune signaling can be orches-
trated from intracellular vesicles and organelles (Kagan, 2012). In
addition, some immune signaling complexes previously thought
to be strictly cytoplasmic may in fact be recruited to specific
compartments containing ligands. In support of this hypothe-
sis, recent data has shown that caspase-1 can accumulate at the
phagosome, suggesting that molecules of the inflammasome are
also recruited to phagosomal compartments. In the B. burgdor-
feri model, we have made strides in understanding the cellular
distribution of different receptors at the cell surface as well as
inside the host cell. However, the role of vesicular trafficking to
different compartments in the B. burgdorferi host response and
B. burgdorferi pathogenesis remains to be explored.
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